A new study has revealed another benefit of the diabetes medication turned weight loss drug Ozempic. Health experts now say it could also help those with alcohol-use disorder. A study published this ...

By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

GLP-1s are being studied as ways to help those with addictive tendencies curb those habits.

Bloomberg: Rong Xu, professor at the School of Medicine, discussed recent research that links semaglutide—the key ingredient in diabetes shot Ozempic and its sister drug Wegovy for obesity—to a ...

A popular diabetes and weight-loss drug reduced people’s craving for drinking alcohol. The results, from the first clinical trial of its kind, suggest that semaglutide may hold promise as a treatment ...

New clinical trial confirms what thousands of users have been saying: the weight loss drug significantly reduces alcohol ...

Use of the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and liraglutide is linked to a lower risk for alcohol use disorder (AUD)–related hospitalizations compared with traditional AUD ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including cancer and arthritis.

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...